ArticleJournal of neuro-oncology2013
Recurrent high-grade glioma treated with bevacizumab: prognostic value of MGMT methylation, EGFR status and pretreatment MRI in determining response and survival.
Christina Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled itcites it